NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Onkos Diagnósticos Moleculares

Onkos Diagnósticos Moleculares

Private
Ribeirão PretoHealthcare & Life Scienceshttps://www.onkos.com.br/

Last Round

Grant

May 1, 2025

Company Overview

Onkos Diagnósticos Moleculares is a biotechnology company that develops molecular diagnostic tests for oncology, specializing in gene expression profiling and genetic markers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

molecular diagnosticsthyroid nodule testinggene expression profilingprecision medicineliquid biopsycancer diagnosticsmicroRNA analysisclinical decision supportmolecular classifierAI diagnosticsoncology testinggermline mutation screeningtumor origin testbiotech lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onkos Diagnósticos Moleculares Comparables

Compare Onkos Diagnósticos Moleculares with similar companies based on industry and business-model similarity.

Onkos Diagnósticos Moleculares comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GeneproDX
86%
Veracyte
73%
OncoTag
72%

Onkos Diagnósticos Moleculares Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2025
AcceleratorNov 1, 2018

Key People

Founding team and executive leadership

Marcos Santos

Founder & CEO

Founding Team

Onkos Diagnósticos Moleculares Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Grew 25% QoQ, from 32 to 40 employees.

Onkos Diagnósticos Moleculares Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onkos Diagnósticos Moleculares Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onkos Diagnósticos Moleculares's valuation, stock price, and market status.

Firmographic Details

HeadquartersRibeirão Preto
Employee Range54
Year Founded2015
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.